Volume 16(8), Supplement 1, November 2025 ISSN 1879-4068 Abstracts of the Annual Conference of the International Society of Geriatric Oncology (SIOG 2025) 20-22 November, 2025, Ghent, Belgium The official journal of the International Society of Geriatric Oncology
Associate Editors Nicolo Matteo Luca Battisti The Royal Marsden NHS, Foundation Trust, London, UK Marije Hamaker Diakones Hospital Utrecht Zeist Doorn Location Zeist, The Netherlands Heidi Klepin Wake Forest University School of Medicine Winston-Salem, NC, USA Jessica Krok-Schoen The Ohio State University Columbus, OH, USA Gabor Liposits Odense University Hospital, Odense, Denmark Kah Poh Loh University of Rochester Medical Center Rochester, NY, USA AnitaO’Donovan The University of Dublin Trinity College Dublin, Ireland Martine Puts University of Toronto Toronto, Canada Ashley Rosko The Ohio State University Columbus, OH, USA Enrique Soto-Perez-de-Celis Salvador Zubiran National Institute of Medical Sciences and Nutrition Ciudad de México, Mexico William Tew Memorial Sloan-Kettering Cancer Center New York, NY, USA Noam VanderWalde The University of Tennessee Health Science Center Memphis, TN, USA Editorial Board Arya Amini City of Hope Department of Radiation Oncology Duarte, CA, USA Thomas Aparicio Saint-Louis Hospital Department of Gastroenterology Paris, France Sukeshi Arora The University of Texas Health Science Center at San Antonio San Antonio, TX, USA Etienne Brain René Huguenin Hospital Saint-Cloud Saint Cloud, France Yanin Chávarri ISalvador Zubirán National Institute of Health Sciences and Nutrition Mexico City, Mexico Tyler Chesney St Michael's Hospital, Bristol, UK Filipe Coutinho Medio Ave Hospital Center Santo Tirso, Portugal Lore Decoster UZ Brussel Brussels, Belgium Efrat Dotan Penn Medicine Philadelphia, PA, USA Divyanshu Dua Central Gippsland Health Service Sale, VIC, Australia Clark DuMontier Brigham and Women's Hospital Boston, MA, USA Rawad Elias University of Massachusetts Chan Medical School - Baystate Regional Campus Springfield, MA, USA Martine Extermann Moffitt Cancer Center Tampa, FL, USA Claire Falandry South Francilien Hospital Centre Corbeil Essonnes, France Marie Flannery University of Rochester Medical Center Rochester, NY, USA Fergal Fleming University of Rochester Medical Center Rochester, NY, USA Chunkit Fung University of Rochester Medical Center Rochester, NY, USA Nikesha Gilmore University of Rochester Medical Center Rochester, NY, USA Nienke de Glas Leiden University Medical Centre The Netherlands M. Regina Gironés Sarrió La Fe University and Polytechnic Hospital Valencia, Spain OzanGuler Baskent University Ankara, Turkey Kristen Haase University of British Columbia, School of Nursing, Faculty of Applied Science Vancouver, BC, Canada Holly Holmes The University of Texas MD Anderson Cancer Center Houston, TX, USA Aminah Jatoi Mayo Clinic Rochester, MN, USA Ravindran Kanesvaran National Cancer Centre Singapore, Singapore Cindy Kenis University Hospitals Leuven Leuven, Belgium Gretchen Kimmick Duke University Hospital Durham, NC, USA Beatriz Korc Memorial Sloan-Kettering Cancer Center New York, NY, USA Anita J. Kumar Janssen Research and Development Belgium Beerse, Belgium Stuart Lichtman Memorial Sloan-Kettering Cancer Center New York, NY, USA Richard Lin Memorial Sloan Kettering Cancer Center New York, NY, USA Lisa M. Lowenstein The University of Texas MD Anderson Cancer Center Houston, TX, USA Andrea Luciani Santa Chiara Hospital Pisa, Italy Jennifer L. Lund The University of North Carolina at Chapel Hill Chapel Hill, NC, USA Cecilia Lund Herlev Hospital Herlev, Denmark Allison Magnuson University of Rochester Rochester, NY, USA Kelly M. McConnell NewYork-Presbyterian Weill Cornell Medical Center, New York, NY, USA June M. McKoy Northwestern University - Feinberg School of Medicine Chicago, IL, USA Mostafa Mohamed University of Rochester Medical Center New York, NY, USA Isacco Montroni Foundation IRCCS National Cancer Institute Milano, Italy Lucinda Morris University of Technology Sydney Faculty of Health Ultimo, Australia Vicki Morrison University of Minnesota at Twin Cities Minneapolis, MN, USA Christian Nelson Memorial Sloan-Kettering Cancer Center New York, NY, USA Nina Neuendorff Ruhr University Bochum Bochum, Germany Nikita NIkita Thomas Jefferson University Division of Population Science Philadelphia, PA, USA RyanNipp The University of Oklahoma Stephenson Cancer Center Oklahoma City, OK, USA Tomohiro F. Nishijima National Hospital Organization Kyushu Cancer Center Fukuoka, Japan Tracey O'Connor Moffitt Cancer Center, Tampa Florida, USA Rebecca Olin University of California San Francisco San Francisco, CA, USA Mackenzi Pergolotti Select Medical Mechanicsburg, PA, USA Sophie Pilleron Luxembourg Institute of Health Ageing, Cancer, and Disparities Research Unit Strassen, Luxembourg Erika Ramsdale University of Rochester Rochester, NY, USA Schroder Sattar University of Saskatchewan College of Nursing Saskatoon, SK, Canada Nicole Saur Indiana University of Pennsylvania Indiana PA, USA Armin Shahrokni Memorial Sloan Kettering Cancer Center New York, NY, USA Manvi Sharma University of Houston Houston, TX, USA Christopher Steer Albury Wodonga Regional Cancer Centre Trust Fund Inc., Albury, NSW, Australia Ishwaria Subbiah The University of Texas MD Anderson Cancer Center Houston, TX, USA Mazie Tsang Mayo Clinic, Division of Hematology and Oncology, Department of Medicine Phoenix, AZ, USA Barbara L. van Leeuwen University Medical Center Groningen, Groningen, The Netherlands Haydee Verduzco Aguirre Salvador Zubiran National Institute of Medical Sciences and Nutrition Ciudad de México, Mexico Ulrich Wedding Friedrich Schiller University Jena Jena, Germany Tanya M. Wildes University of Nebraska Medical Center Division of Oncology and Hematology Omaha, NE, USA Hans Wildiers KU Leuven Leuven, Belgium Grant R. Williams Lewis and Faye Manderson Cancer Center Tuscaloosa, AL, USA Melisa Wong Kaiser Permanente Northern California San Francisco, CA, USA
JOURNAL OF GERIATRIC ONCOLOGY Volume 16(8), Supplement 1, November 2025 Editorial Board Editor-in-Chief Supriya Mohile University of Rochester Medical Center Rochester, NY, USA Deputy Editors Siri Rostoft University of Oslo Oslo, Norway Shabbir M.H. Alibhai University Health Network Toronto, Canada Social Media Editor William Dale City of Hope Duarte, CA, USA Founding Editor Matti S. Aapro Multidisciplinary Oncology Institute Clinique de Genolier Genolier, Switzerland Past Editor Arti Hurria Director, Cancer and Aging Research Program City of Hope Duarte, CA, USA Advisory Board Lodovico Balducci Moffitt Cancer Center Tampa, FL, USA Harvey Cohen Duke University Hospital Durham, NC, USA Jean-Pierre Droz Centre Léon Bérard Lyon, France E. Margaret Kemeny Icahn School of Medicine at Mount Sinai New York, NY, USA Amsterdam• Boston • London • NewYork • Oxford • Paris • Philadelphia • SanDiego • St. Louis
JOURNAL OF GERIATRIC ONCOLOGY Volume 16(8), Supplement 1, November 2025 Abstracts of the Annual Conference of the International Society of Geriatric Oncology (SIOG 2025) 20-22 November, 2025, Ghent, Belgium Publication of this Abstract Supplement is supported by the International Society of Geriatric Oncology (SIOG) Disclaimer: The Annual Conference of the International Society of Geriatric Oncology abstracts in this supplement have not been reviewed by the Journal of Geriatric Oncology Editors. The abstracts were reviewed, selected, and approved for publication by the Scientific Programme Committee of the Annual Conference of the International Society of Geriatric Oncology. Neither Journal of Geriatric Oncology nor Elsevier are responsible for errors or omissions in the abstracts. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein.
JOURNAL OF GERIATRIC ONCOLOGY Volume 16(8), Supplement 1, November 2025 Publication of this Abstract Supplement is supported by the International Society of Geriatric Oncology (SIOG) CONTENTS SIOG 2025 Annual Conference Abstracts - Oral Presentation SIOG2025-OA-001 - Inclusion of older patients with dementia on oncology clinical trials: Procedures and outcomes from implementing capacity to consent procedures in a geriatric oncology intervention trial 102362 SIOG2025-OA-002 - Impact of immune-related adverse events on quality of life and physical functioning in older patients with solid tumors treated with immune checkpoint inhibitors 102362 SIOG2025-OA-003 - The E-intervention for protein intake and resistance training to optimize function (E-PROOF) study: Initial findings 102362 SIOG2025-OA-005 - Building the cancer and aging research group (CARG) geriatric oncology therapy optimization (GOTO) program research infrastructure: Implementation of 6 patient-centered geriatric oncology trials 102362 SIOG2025-OA-006 - Comparison of the prevalence of patient-reported and clinician-graded cognitive symptomatic adverse events in older patients with advanced cancer 102362 SIOG2025-OA-007 - Assessment of risk of bias in mortality risk prediction models for older adults with cancer: A systematic review from YSIOG and SIOG NAHS members 102362 SIOG2025-OA-008 - Pretreatment cognitive impairment and treatment tolerability in older patients with advanced cancer receiving systemic therapy 102362 SIOG2025-OA-009 - A decade of immune checkpoint inhibitors in lung cancer: Age-specific risks of immune-related adverse events 102362 SIOG2025-OA-010 - Evaluation of pragmatic Geriatric Assessment (pGA) for the prediction of toxicity and outcomes in older patients scheduled for CAR-T-cellor bispecific antibody therapy: GA-ACT trial 102362 SIOG2025-OA-011 - A decisional intervention for older patients with acute myeloid leukemia (AML): A pilot randomized controlled trial (RCT) 102362 SIOG2025-OA-012 - Trajectories of older patients admitted to oncological geriatric rehabilitation in the Netherlands: A nationwide descriptive study on patient characteristics, care trajectories and outcomes 102362 SIOG2025-OA-013 - Biomarker analysis of the RibOB trial: Ribociclib and Letrozole in first line in≥70years women with HR-positive HER2-negative advanced breast cancer 102362 SIOG2025-OA-014 - Long-term quality of life and physical functioning after surgical metastasectomy with curative intent in older patients with metastasized colorectal cancer 102362 SIOG2025-OA-016 - Health-related quality of life (HRQoL) in older patients with HER2-positive early breast cancer treated with chemotherapy and anti-HER2 therapy: An APHINITY trial sub-group analysis 102362 SIOG2025-OA-017 - Using Geriatric Core Data Set (GCODE) to predict mortality in older patients with cancer: Development and external validation 102362 SIOG2025-OA-018 - Will European countries be able to meet the growing demand for radiotherapy due to an aging population by 2050? 102362 SIOG2025-OA-019 - Patient-reported symptom burden and cognitive decline in older adults with lymphoma undergoing chemotherapy: Impact of disease stage 102362 SIOG2025-OA-021 - Utility of genomic assays to guide treatment planning in patients aged 70 and older with early-stage breast cancer enrolled in FLEX 102362 SIOG2025-OA-022 - R-miniCHOP +/-acalabrutinib results in comparable serious adverse event rates in older adults with untreated DLBCL 102362 SIOG2025-OA-023 - Impact of geriatric impairments on outcomes of single-agent immunotherapy in solid tumors 102362 Miscellaneous topics - Poster Presentation SIOG2025-P-003 - Teaching geriatric oncology to medical students: A pilot educational intervention in Portugal 102386 SIOG2025-P-004 - Improved survival through comprehensive geriatric assessment in older adults with myelodysplastic neoplasms and acute myeloid leukemia: A Latin American perspective 102386 SIOG2025-P-008 - Breast cancer systemic anticancer treatment delivery in older patients and a stakeholder survey for implementing an oncogeriatric service what are the easy wins? 102386 SIOG2025-P-009 - Predicting the Risk of Death with New Indexes in Community-dwelling Elderly (PREDIC): Development of new 5- and 10-year mortality prediction models 102386 SIOG2025-P-010 - Radiation-induced lung and skin toxicity in young and aged mice 102386 SIOG2025-P-012 - Geriatric assessment in patients aged 70 and over considered for CAR-T therapy: A descriptive study 102386 SIOG2025-P-013 - Prognostic impact of geriatric assessment in acute myeloid leukemia patients treated with Azacitidine-Venetoclax 102386 SIOG2025-P-015 - Overlap between frailty, malnutrition and probable sarcopenia among older patients with newly diagnosed multiple myeloma 102386 SIOG2025-P-017 - E-warm model-based palliative care promotes QoL in driver-gene-negative advanced NSCLC: A LGCM approach 102386 SIOG2025-P-018 - Geriatric cancer in India 102386 SIOG2025-P-019 - A prospective study of efficacy and safety of Ribociclib and Letrozole in first line in ≥70years women with HR-positive advanced breast cancer: RibOB study 102386 SIOG2025-P-020 - Ambulatory falls in the outpatient population with cancer: A descriptive project and gap analysis of current practice 102386 SIOG2025-P-021 - Feasibility of online remote symptom monitoring for older patients receiving systemic cancer therapy (TS-PAC) 102386 SIOG2025-P-022 - From MetaGENUA® to the “Modified MetaGENUA®”: Improved prognostic stratification of one-year mortality in elderly cancer patients 102386 (Contents continued on inside back cover)
SIOG2025-P-025 - Toward precision care: Integrating G8 and VES-13 screening in older cancer patients undergoing radiation therapy 102386 SIOG2025-P-026 - Falls among the older patients treated for cancer in Normandy's outclinics: Screening and prevention (CHUPACHOUP study) 102386 SIOG2025-P-027 - Decision-making in cancer treatment: Key factors for older adults 102386 SIOG2025-P-028 - How to analyze longitudinal patientreported outcomes in populations with high mortality rates – A clinical example in older patients with cancer 102386 SIOG2025-P-029 - Impact of skeletal muscle mass and density on postoperative outcomes among older patients following colorectal cancer resection 102386 SIOG2025-P-030 - A wide variability in the identification and management of geriatric syndromes in a French and a British oncology settings, with inconsistent corrective interventions for frailty 102386 SIOG2025-P-031 - An overview of the Geriatric and Palliative Care Clinic (CARE-Pall): A transformative model of integrative geriatric and palliative care 102386 SIOG2025-P-032 - Bridging research and clinical practice with the Center for Implementation Research in Cancer in Later Life (CIRCL) 102386 SIOG2025-P-033 - Impact of age and comorbidities on treatment outcomes in Non-Hodgkin Lymphoma: A monocentric real-life retrospective study 102386 SIOG2025-P-034 - Redefining the use of a first-line FOLFIRINOX-like regimen in older adults with metastatic pancreatic cancer: Updated analysis 102386 SIOG2025-P-035 - Social frailty among older adults living with co-morbid cancer and dementia, who are receiving radiotherapy. A longitudinal narrative case study 102386 SIOG2025-P-036 - Evaluation of potentially inappropriate medications in older people with cancer hospitalized at the Latin American Cancer Center 102386 SIOG2025-P-037 - The impact of ethnic disparity on treatment of primary breast cancer in older women 102386 SIOG2025-P-040 - Active surveillance in basal cell carcinoma: Experiences of patients and proxies 102386 SIOG2025-P-041 - Geographic disparities in prostate cancer MRI utilization: The role of MRI provider availability in mitigating rural and regional gaps 102386 SIOG2025-P-043 - Optimizing cancer care for older adults: The impact of embedded occupational therapy in the Cancer Older People's Service (COPS) 102386 SIOG2025-P-045 - Early advance care planning; experiences of patients with the ‘My CARE, now and later’ conversation card at a geriatric outpatient clinic; a qualitative study 102386 SIOG2025-P-046 - Healthcare professionals' experiences using the Outcome Prioritization Tool (OPT) to elicit patient preferences: A qualitative study 102386 SIOG2025-P-047 - Discussing patient goals and preferences during decision-making with patients with head and neck cancer 102386 SIOG2025-P-048 - Liquid biopsy for elderly patients with unresectable EGFR mutant NSCLC with different patterns of frailty 102386 SIOG2025-P-049 - Implicit steering during shared decision-making with head and neck cancer patients 102386 SIOG2025-P-050 - Efficacy of a hybrid exercise program on falls and fear of falling in older adults with cancer: Results from a randomized controlled trial 102386 SIOG2025-P-051 - Association of Balducci geriatric fitness categorization with overall survival in older adults with cancer: A retrospective cohort study 102386 SIOG2025-P-053 - The role of locoregional anaesthesia in older women having surgery for breast cancer 102386 SIOG2025-P-054 - Implementation of the practical geriatric assessment for older adults with newly diagnosed glioblastoma 102386 SIOG2025-P-055 - Real-world tolerability and efficacy of CAPOX in older adults with gastrointestinal cancer 102386 SIOG2025-P-056 - Exploring dynamic changes in geriatric assessments of older adults upon allogeneic hematopoietic stem cell transplantation: A pilot single-center prospective cohort study 102386 SIOG2025-P-057 - Value elucidation in geriatric oncology care: A participatory development study on a dialogical instrument for clinical practice 102386 SIOG2025-P-058 - Inpatient goals of care discussions among older adults with cancer 102386 SIOG2025-P-059 - MoCA vs. MMSE: Which tool should be used to screen for cognitive impairment in geriatric oncology 102386 SIOG2025-P-060 - Quality of life and physical functioning of older patients treated with palliative chemotherapy for metastatic colorectal cancer: A population-based study 102386 SIOG2025-P-062 - Modified DiabetesSelf-management Education (DSME) for prostate cancer patients with T2DM: A pilot clinical trial 102386 SIOG2025-P-063 - Impact of a dedicated geriatric oncology tumor-board on therapeutic decision-making in patients aged 70 and over with cancer: The OncoBoardAge study 102386 SIOG2025-P-066 - Assessment of physical activity levels and functional rehabilitation needs in older patients undergoing systemic oncological treatment 102386 SIOG2025-P-067 - Implications of vitamin D levels in elderly non-small cell lung cancer patients: A retrospective cohort analysis 102386 SIOG2025-P-068 - Metabolic dysfunction following treatment for prostate cancer 102386 SIOG2025-P-070 - Development of an expedited pathway for accessing a personalized exercise program for older adults starting on cancer treatment: A quality improvement (QI) initiative 102386 SIOG2025-P-071 - Enhanced lung cancer clinic for older patients: One year experience improving its operational model at The Christie cancer centre 102386 SIOG2025-P-072 - Blood tests identify expanded eligibility and prolonged survival across all ages 102386 SIOG2025-P-074 - Enhanced lung cancer clinic for older patients: One year experience improving clinical outcomes at The Christie cancer centre 102386 SIOG2025-P-075 - A study of comprehensive geriatric assessment, chemotherapy-associated adverse events and survival outcomes in geriatric Indian cancer patients 102386 SIOG2025-P-077 - Facilitating shared decision-making in geriatric oncology an interprofessional multicenter pilot-study 102386 SIOG2025-P-078 - Management challenges of testicular germ cell tumors in patients over 65: A case series highlighting the role of geriatric assessment in guiding chemotherapy decisions 102386 SIOG2025-P-080 - Comprehensive analysis of genomic and transcriptomic landscapes in elderly non-small cell lung cancer in China: A single-center retrospective study 102386 SIOG2025-P-081 - Exploring stereotactic radiotherapy in elderly pancreatic cancer patients: A safe and effective approach? 102386 SIOG2025-P-082 - Dizziness and impaired postural balance in older patients receiving chemotherapy treatment a systematic review and meta-analysis 102386 (Contents continued from outside back cover)
SIOG2025-P-083 - Serum thymidine kinase activity in older patients with HR-positive and HER2-negative advanced breast cancer treated with ribociclib and letrozole in the RibOB trial 102386 SIOG2025-P-084 - Comprehensive geriatric assessment predicts early death among older adults with newly diagnosed acute myeloid leukemia: Results from NCT05458258 102386 SIOG2025-P-086 - Feasibility and predictive utility of implementing a modified practical geriatric assessment for older adults with gastrointestinal cancer 102386 SIOG2025-P-087 - Integrating oncogeriatric principles into hematologic cancer care 102386 SIOG2025-P-088 - Predicting treatment toxicity, mortality, and multidisciplinary care requirements in older patients with cancer undergoing systemic therapy: A real-world analysis 102386 SIOG2025-P-089 - Baseline assessment of quality of life, treatment toxicity, and prognosis among geriatric patients with cancer at the cancer diseases hospital in Zambia 102386 SIOG2025-P-092 - Feasibility of using a triaxial accelerometer to assess physical activity (PA) in older adults with myeloid neoplasms (MNs): A single-arm pilot study 102386 SIOG2025-P-094 - Perspectives of Dutch oncologists on the evaluation of frailty in the Netherlands: A qualitative study 102386 SIOG2025-P-095 - Age-related outcomes of liver metastasectomy for metastatic colorectal cancer: A retrospective analysis 102386 SIOG2025-P-096 - Engaging oncology nurses in geriatric screening: A year-long implementation project to integrate geriatric 8 screening in older adults in community oncology practices 102386 SIOG2025-P-097 - Implementing a structured geriatric oncology pathway in routine cancer care: Feasibility and outcomes from a Swiss pilot project 102386 SIOG2025-P-099 - Stereotactic Ablative Body Radiotherapy (SABR) for localized renal cell carcinoma (RCC) in geriatric patients: A single centre review 102386 SIOG2025-P-100 - Clinician perspectives on a novel geriatric assessment tool for older adults with cancer 102386 SIOG2025-P-101 - Utility of the elderly prognostic index in predicting overall survival in older adults with diffuse large B-cell lymphoma: Geriatric assessment in a Mexican tertiary hospital 102386 SIOG2025-P-103 - Implementing a geriatric oncology program in a Midsize Swiss Cancer Center: Feasibility and early results 102386 SIOG2025-P-104 - Smartphone use to predict outcomes in elderly undergoing major oncologic procedures: The Smartph-old test 102386 SIOG2025-P-105 - Systemic anti-cancer treatment in older patients with sarcoma: The experience of St. Vincent's Sarcoma Network Ireland 102386 SIOG2025-P-106 - The impact of a 21-gene expression assay on the management and clinical outcomes of older women with node-negative, oestrogen-positive, early breast cancer 102386 SIOG2025-P-108 - Sarcopenia implications in postoperative colorectal cancer surgery: A preliminary study 102386 SIOG2025-P-109 - Home-based, tele-supervised exercise prehabilitation for older adults undergoing hepatobiliary tumor resection: A pilot study 102386 SIOG2025-P-111 - Real world (RW) efficacy and toxicity of Ipilimumab (ipi)/Nivolumab(nivo) plus chemotherapy for older patients (pts) with PD-L1 negative, advanced non-small cell lung cancer (aNSCLC) 102386 SIOG2025-P-112 - Effect of geriatric assessment with patient coaching on unplanned hospitalizations, adverse events and overall survival in older patients with cancer: Secondary endpoints from GoncocCOACH study 102386 SIOG2025-P-114 - Which frailty tool best predicts mortality in chemotherapy-naïve elderly cancer patients? 102386 SIOG2025-P-115 - The impact of geriatric assessments on end-of-life outcomes for older adults with cancer 102386 SIOG2025-P-116 - Real-world treatment patterns and outcomes in elderly patients with metastatic colorectal a Portuguese single-center experience 102386 SIOG2025-P-117 - MobiTest study: Comparison of mobility tests in geriatrics 102386 SIOG2025-P-118 - Perception of the oncology team regarding the oncogeriatric assessment program in a public hospital in Chile: One year post-implementation 102386 SIOG2025-P-119 - Onco-geriatric services across Europe 102386 SIOG2025-P-122 - External validation of a comprehensive geriatric assessment-based nomogram for predicting nutritional risk in elderly Asian cancer patients 102386 SIOG2025-P-123 - Participation in leisure activities among older adults with cancer receiving radiotherapy 102386 SIOG2025-P-125 - Changes in quality of life throughout the illness trajectory of older adults with cancer: A systematic review 102386 SIOG2025-P-126 - Evaluation of treatment strategies for colorectal cancer in older adults: A scoping review of observational studies 102386 SIOG2025-P-127 - Differences in treatment and outcome between young and older patients with liver metastases of colorectal cancer 102386 SIOG2025-P-128 - Long term evolution of functional status (FS) after robotic surgery (RS) for older patients (pts) with colorectal cancer (CRC): Interim analysis of the Robo-G study 102386 SIOG2025-P-129 - Gait speed and nutritional status as predictors of treatment and survival outcomes in elderly patients with metastatic lung cancer 102386 SIOG2025-P-130 - Validation of the online prediction tool PREDICT Breast Version 3 in older patients with breast cancer 102386 SIOG2025-P-131 - Geriatric assessment and posthospitalization trajectories in older hospitalized patients with advanced cancer: A pilot observational study 102386 SIOG2025-P-133 - Wearable-derived trajectories of physical recovery after oncologic surgery in adults aged 70+: A pilot study 102386 SIOG2025-P-135 - Change in performance status and quality of life in older adults with advanced gastrointestinal cancer: A longitudinal study 102386 SIOG2025-P-138 - Development and evaluation of a patient-reported G8 screening tool on Epic MyChart for older cancer patients 102386 SIOG2025-P-139 - Exploring urinary incontinence in clinical practice for older adults with cancer 102386 SIOG2025-P-140 - Sleep and cancer in older adults: A systematic scoping review 102386 (Contents continued from inside back cover)
SIOG2025-P-141 - Real-world efficacy and toxicity of immunotherapy in elderly patients with lung cancer 102386 SIOG2025-P-142 - Primary CNS lymphoma: A review of outcome & toxicity in geriatric patients receiving high-dose methotrexate based chemotherapy in tertiary care hospital with medical oncology facilities 102386 SIOG2025-P-143 - Provider communication, referrals about treatment costs, and their association with financial well-being among older adults with cancer 102386 SIOG2025-P-146 - Beyond the trial: Real-world insights into fracture risk among patients with advanced prostate cancer 102386 SIOG2025-P-151 - Supporting older adults with cancer and their support person through geriatric assessment and remote exercise and education: The SOAR trial initial feasibility results 102386 SIOG2025-P-152 - Strategies for implementing a patient priorities approach in breast cancer survivorship for older adults 102386 SIOG2025-P-153 - Real-world efficacy and safety of apalutamide in elderly and frail patients with metastatic castration-sensitive prostate cancer 102386 SIOG2025-P-154 - Single centre experience of weekly ultra-hypofractionated radiotherapy for muscle invasive bladder cancer in the older patient population 102386 SIOG2025-P-155 - Quality of life in older women with breast cancer after treatment with surgery or primary endocrine therapy 102386 SIOG2025-P-157 - Management of surgically resectable colorectal liver metastases in older patients 102386 SIOG2025-P-158 - Impact of adjuvant chemotherapy in early-stage pancreatic ductal adenocarcinoma by age 102386 SIOG2025-P-161 - Adapting the patient priorities care approach to breast cancer survivorship following a user-centered design 102386 SIOG2025-P-164 - Efficacy and safety of immune checkpoint inhibitors in older patients with advanced gastric cancer: A retrospective analysis 102386 SIOG2025-P-165 - Treatment-related toxicities and functional outcomes in vulnerable older adults with metastatic pancreatic cancer: Analysis from ECOGACRIN EA2186 102386 SIOG2025-P-166 - Leveraging Natural Language Processing (NLP) to identify relapse in medical notes 102386 SIOG2025-P-168 - Early unplanned hospitalization risk after novel hormonal therapy initiation in metastatic prostate cancer: Impact of disease type, treatment, and race 102386 SIOG2025-P-169 - Implementation and impact of a new geriatric oncology unit in Mexico 102386 SIOG2025-P-172 - The Liver cancer and Frailty in Elderly (LIFE) study: Geriatric assessments in patients with varying liver dysfunction and advanced hepatocellular carcinoma (HCC) 102386 SIOG2025-P-174 - Estimating opportunistic screening rates for breast and colorectal cancer in older adults across European countries 102386 SIOG2025-P-175 - The benefits of geriatric assessmentdriven interventions in older adults with cancer: A SIOG taskforce systematic review 102386 SIOG2025-P-183 - Informal caregiver burden in geriatric oncology: Insights from a multicenter cohort study 102386 SIOG2025-P-184 - Infection risk in older patients with cancer undergoing chemotherapy: A real-world analysis 102386 SIOG2025-P-186 - Patterns of cancer cases admitted in a geriatric tertiary care unit in North India- a subgroup analysis of a prospective observational study 102386 SIOG2025-P-187 - Comprehensive geriatric assessment prior to chemotherapy in older adults with cancer: An integrated care model in Brazil's private healthcare system 102386 SIOG2025-P-188 - Tumor resection differences in Glioblastoma Multiforme (GBM) between patients over and under 70years of age[A1] and impact in overall survival (OS) 102386 SIOG2025-P-189 - Unique nutritional requirements of geriatric cancer patients: Integrating geriatric nutrition and oncology 102386 SIOG2025-P-190 - Primary care clinicians' perceptions of 4M-based survivorship care and confidence in managing older cancer survivors 102386 SIOG2025-P-192 - The positive change in perspectives among healthcare workers toward older adults living with cancers with introduction of geriatric oncology and monthly tele-MDT programme 102386 SIOG2025-P-195 - Advancing precision oncology translational research through comprehensive biobanking for older adults with cancer: Insights from the Cologne Surgical Oncology Biobank 102386 SIOG2025-P-196 - Feasibility analysis of geriatric assessment and remote symptom monitoring in older men with advanced prostate cancer on androgen receptor pathway inhibitor 102386 SIOG2025-P-197 - Recovery after major elective surgery in frail older adults: Preliminary results from the frail sub-study of the FIT after surgery study 102386 SIOG2025-P-198 - Exploring the lived experiences of racialized older adults: Results from the NUANCE study 102386 SIOG2025-P-199 - Tailoring oncologic care through CGA: Multidisciplinary interventions across frailty groups in older adults with esophagogastric cancer 102386 SIOG2025-P-200 - An assessment of patient feasibility and usability of the Comprehensive Health Assessment for My Plan (CHAMP) tool for older adults with cancer 102386 SIOG2025-P-201 - Effectiveness of the senior program to initiate and maintain adaptive physical activity among older adults with cancer “IMAPAC-séniors” 102386 SIOG2025-P-203 - Longitudinal assessment of Quality of Life in older Indian women with breast cancer 102386 SIOG2025-P-204 - Is SCreening of the Older PErson with Cancer (SCOPE-C) a better scale for geriatric assessment in cancer patients? A real-world experience from South India 102386 SIOG2025-P-205 - The prevalence and association of frailty and polypharmacy with the retention of older cancer survivors in the COACH study 102386 SIOG2025-P-206 - Assessment of frailty using two different tools in older cancer patients treated at a tertiary geriatric care hospital from South India 102386 SIOG2025-P-207 - Need and uptake of Geriatric Assessment-guided interventions in older Indian patients with cancer 102386 SIOG2025-P-208 - A Phase 3 RCT evaluating impact of cognitive and exercise intervention to prevent cognitive decline in older cancer patients on systemic therapy feasibility analysis 102386 SIOG2025-P-210 - Insights into Supportive Care (SC) Services provided to Older vs. Younger Adults with Lung Cancer treated at The Ohio State University Comprehensive Cancer Center 102386 SIOG2025-P-211 - Implementation of Comprehensive Geriatric Assessment (CGA) in a geriatric tertiary care hospital from South India A real world experience 102386 (Contents continued)
SIOG2025-P-217 - Experiences of interventional radiologists in the planning, execution and follow up of TAE and TACE for the local control of hepatocarcinoma in older adults 102386 SIOG2025-P-219 - Tolerability of doublet therapy in elderly (≥75years) with metastatic prostate cancer: A single centre experience study 102386 SIOG2025-P-220 - Associations between a deficit accumulation electronic frailty index and fatigue with overall survival in a prospective cohort of colorectal cancer patients: Differences by age 102386 SIOG2025-P-221 - Use of ward-based acute geriatric rehabilitation to enable older in-patients with cancer to receive outpatient oncological treatment after hospital discharge 102386 SIOG2025-P-223 - The impact of geriatric assessment on decision-making in older adults with cancer prior to surgery 102386 SIOG2025-P-224 - The GERHOQ-study: Determinants of survival and treatment pathways in hemato-oncology in older patients 102386 SIOG2025-P-225 - The care at home model for older adults undergoing major oncological surgery 102386 SIOG2025-P-226 - Cancer-Related Fatigue (CRF) in older adults undergoing Systemic Anti-Cancer Treatment (SACT): Findings from occupational therapy (Senior Adult Oncology Programme) 102386 SIOG2025-P-227 - External validation of the HEMA-4 score: A simple clinico-biological tool to identify frailty in clinically fit older patients with hematological malignancies 102386 SIOG2025-P-228 - What are the non-physical activity benefits of exercise and nutrition interventions in older adults with cancer? A SIOG Taskforce systematic review 102386 SIOG2025-P-229 - From diagnosis to decision: The impact of a joint geriatric-oncology clinic in lung cancer care 102386 SIOG2025-P-230 - Handgrip strength and risk of severe chemotherapy toxicity in a sample of geriatric Mexican cancer patients: A descriptive study 102386 SIOG2025-P-232 - Reducing risk of harm during systemic anticancer treatment (SACT) in older people with moderate risk of hyperglycaemic toxicity 102386 SIOG2025-P-233 - Development of a medication review intervention in ambulatory older adults with cancer 102386 SIOG2025-P-234 - Age-related disparities in gastric cancer: A retrospective cohort analysis 102386 SIOG2025-P-235 - Geriatric assessment in oncology: Knowledge and clinical practices among oncologists inMorocco 102386 SIOG2025-P-236 - A mixed methods study of Geriatric Oncology Patient Navigation Roles Worldwide 102386 SIOG2025-P-237 - Impact of frailty and sarcopenia on health-related quality of life in older adults with cancer: Results from a prospective oncogeriatric cohort 102386 SIOG2025-P-238 - Allostatic load, multimorbidity, and overall and cancer-specific survival among U.S. adults ≥60years in the National Health and Nutrition Examination Survey (NHANES) 102386 SIOG2025-P-239 - K-ras gene mutation as an early prognostic marker for localized colorectal cancer in elderly patients 102386 SIOG2025-P-240 - Evaluation of older patients' experience in a joint oncogeriatric consultation for lung cancer 102386 SIOG2025-P-241 - Disparities in emergency department use among older adults with cancer: Insights from comprehensive geriatric assessment 102386 SIOG2025-P-242 - Age-related disparities in colorectal cancer presentation and pathology: A retrospective cohort study 102386 SIOG2025-P-243 - Re-evaluation of frailty is necessary between neoadjuvant chemotherapy and surgery in esophageal cancer patients 102386 SIOG2025-P-245 - The contribution of laparoscopy in staging of gastric adenocarcinoma in elderly patients 102386 SIOG2025-P-246 - Evaluating the role of PFFS in predicting outcomes in high stress thoracic surgeries 102386 SIOG2025-P-248 - Association of cancer cachexia with loss of functionality, sarcopenia, and loss of physical performance in older adults with cancer 102386 SIOG2025-P-250 - Screening and management of pulmonary nodules in nonagenarians: Application of artificial intelligence in geriatric oncology aligned with choosing wisely principles 102386 SIOG2025-P-253 - Experience of radiotherapy with geriatric assessment in octogenarian (80–89 age group) cancer patients 102386 SIOG2025-P-256 - Addressing the needs and concerns of older persons facing cancer diagnosis: A reflexive thematic analysis to inform co-design of a centralized cancer diagnosis program 102386 SIOG2025-P-257 - Implementing a nurse-led geriatric screening and management model of care in the ambulatory oncology care setting: A quality improvement initiative 102386 SIOG2025-P-259 - Impact of the Integrated Oncological Decision-Making Model (IODM) on health outcomes and healthcare costs in elderly patients with lower gastrointestinal tumors 102386 SIOG2025-P-260 - The Edmonton Frail Scale as a predictor of chemotherapy-related adverse events in elderly cancer patients 102386 SIOG2025-P-261 - Immunotherapy in older patients with advanced melanoma: Treatment response and toxicities 102386 SIOG2025-P-262 - Nursing involvement in cancer treatment decision making among older adults: A scoping review 102386 SIOG2025-P-263 - Treatment approaches and survival outcomes in older breast cancer patients: A Hong Kong–UK comparison 102386 SIOG2025-P-264 - Effect of gantry rotation and dose rate on bladder volume in geriatric prostate cancer radiotherapy 102386 SIOG2025-P-265 - Evaluation of baseline geriatric syndromes, quality of life, and mortality in older patients with prostate cancer treated with Enzalutamide at an Oncological Center in Chile 102386 SIOG2025-P-266 - Toward person-centred, age friendly care: The development of an Optimal Care Pathway for older adults with cancer as part of the Australian Cancer Plan (ACP) 102386 SIOG2025-P-271 - Impact of proactive support on Systemic Anti-Cancer Therapy (SACT) completion rates in a frail cancer population 102386 SIOG2025-P-272 - Integrating geriatric assessment into the gynecologic tumor board: A descriptive study from a university hospital 102386 SIOG2025-P-273 - A cross-sectional profile of the burden of frailty in older adults initiating systemic anticancer therapy at a regional cancer centre 102386 (Contents continued)
SIOG2025-P-275 - Toxicity of chemotherapy in elderly patients with colorectal cancer: Analysis of hospital case series 102386 SIOG2025-P-276 - Implementation and evaluation of the s-G8 patient reported frailty assessment in an oncology outpatient department 102386 SIOG2025-P-277 - Therapeutic decision-making in older adults with cancer: Concordance between geriatric assessment and interdisciplinary teams 102386 SIOG2025-P-280 - Preoperative anemia severity in cancer surgeries of patients aged 80+: An overlooked risk factor? 102386 Trials in progress - Poster Presentation SIOG2025-P-282 - Patient and oncologist expectations of physical function among older adults with acute myeloid leukemia 102664 SIOG2025-P-283 - Geriatric oncology in medical education: Optimising undergraduate curriculum design and implementation in the United Kingdom 102664 SIOG2025-P-284 - Implementing geriatric assessments using the practical geriatric assessment in older adults being evaluated for cellular therapies at a safety-net hospital 102664 SIOG2025-P-285 - Integrating geriatric oncology into trainee-led NHS quality improvement: Use of Rockwood Clinical Frailty Score in gastrointestinal cancer MDT in the United Kingdom 102664 SIOG2025-P-286 - Interventions to improve health care provider implementation and patient adherence of patients to recommendations on geriatric assessment and management in older adults: A scoping review 102664 SIOG2025-P-287 - Characterizing goals-of-care discussions in geriatric oncology clinic: A retrospective chart review 102664 SIOG2025-P-290 - Digital frailty screening for older adults with cancer: A digital screening to optimize resource allocation and improve efficiency 102664 SIOG2025-P-291 - Research on understanding and dissemination of geriatric assessment 102664 SIOG2025-P-293 - TRAJECT – Uncovering shared and specific experiences in end-of-life trajectories of older people living with different types of cancer 102664 SIOG2025-P-295 - Implementation of a comprehensive geriatric assessment in the routine care of older patients with cancer: A bicentric feasibility study 102664 SIOG2025-P-296 - Integrating the practical geriatric assessment (PGA) into oncology practice: Feasibility and early lessons learned 102664 Care Model Abstracts - Oral Presentation SIOG2025-CM-OA-001 - Older adults with cancer clinic at Princess Margaret Cancer Centre: A multidisciplinary comprehensive care model of geriatric oncology 102737 SIOG2025-CM-OA-002 - Integrated oncological decisionmaking model: Creating a practice of patient-centred decision-making 102737 SIOG2025-CM-OA-003 - Comprehensive geriatric cancer care model in a tertiary geriatric cancer care hospital in South India 102737 SIOG2025-CM-OA-004 - The Royal Marsden Senior Adult Oncology Programme 102737 SIOG2025-CM-OA-005 - Scaling Geriatric Oncology through embedded practical geriatric assessment and multidisciplinary pathways 102737 Care Model Abstracts - Poster Presentation SIOG2025-CM-P-001 - Development and Growth of a Geriatric Oncology care model in a geographically fragmented tertiary cancer center 102743 SIOG2025-CM-P-002 - The University of Rochester Specialized Oncology Care and Research for our Elders Clinic: Evolution of a traditional consultative geriatric assessment model to allow regional expansion 102743 SIOG2025-CM-P-004 - Onco-geriatric service within oncological department 102743 SIOG2025-CM-P-005 - National Cancer Centre Singapore (NCCS) Geriatric Oncology Care Program (GO Care) 102743 SIOG2025-CM-P-006 - ARTA-ATTACK study: Assessment of sarcopenia, frailty, and neurocognitive impairment in patients with metastatic hormone sensitive prostate cancer treated with androgen receptortargeted agents 102743 SIOG2025-CM-P-007 - Structuration of geriatric oncology in France, in support of the Regional Onco-Geriatric Coordination Units, enables innovation in the care of older adults with cancer 102743 SIOG2025-CM-P-009 - Stronger together: The integrated inpatient care model for older adults with cancer at Brown University 102743 SIOG2025-CM-P-011 - Oncogeriatric assessment protocol in a public hospital in Chile: An ongoing challenge 102743 SIOG2025-CM-P-013 - Structured care pathway for older patients with cancer in UZ Leuven, Belgium: The geriatric oncology program 102743 SIOG2025-CM-P-014 - The Geriatric and Palliative Care Clinic (CARE-Pall): A transformative model of integrative geriatric and palliative care 102743 SIOG2025-CM-P-015 - The Saint-Luc geriatric oncology care pathway 102743 SIOG2025-CM-P-016 - Interdisciplinary oncogeriatric care: The strengths and weaknesses of the consultation of Fribourg in Switzerland 102743 SIOG2025-CM-P-017 - Erasmus MC – Geriatric Oncology model in a tertiary, Academic Teaching Hospital in the Netherlands 102743 SIOG2025-CM-P-018 - Implementation of a geriatric oncology unit in a Tunisian Medical Oncology Department: A single-center experience 102743 SIOG2025-CM-P-019 - A hybrid model of care to promote integration and resilience in senior adult cancer services 102743 SIOG2025-CM-P-021 - Personalized cancer care: Considering other-cause mortality 102743 SIOG2025-CM-P-022 - Integrated geriatric oncology workflow at the Oncology Centre Thun – Spiez – Berner Oberland 102743 SIOG2025-CM-P-023 - Geriatric Oncology pilot implementation model of care at the Chirec Cancer Institute 102743 SIOG2025-CM-P-024 - Implementation of a geriatric oncology program in the medical oncology department of Mohammed VI University of Tangier, Morocco 102743 SIOG2025-CM-P-025 - Breaking barriers: Building an integrated oncogeriatric model for lung cancer 102743 SIOG2025-CM-P-027 - Oncogeriatrics collaboration programs: A look to another type of oncogeriatrics healthcare assistance in Spain 102743 (Contents continued)
SIOG2025-CM-P-029 - Oncogeriatric Evaluation Protocol in a Chilean Cancer Center: A mixed proposal center approach 102743 SIOG2025-CM-P-030 - Geriatric oncology Mul > disciplinary clinic: Brown's commitment to personalized cancer care 102743 SIOG2025-CM-P-032 - Ward-based acute geriatric rehabilitation with comprehensive geriatric assessment and multidisciplinary management in a specialized oncogeriatric unit for older cancer 102743
Aims and Scope The Journal of Geriatric Oncology is an international, multidisciplinary journal which is focused on advancing research in the treatment and survivorship issues of older adults with cancer, as well as literature relevant to education and policy development in geriatric oncology. TheJournal of Geriatric Oncologypublishes original research articles, review articles, clinical trials, treatment guidelines, short communications and letters to the editor which comment on previously published work. The Journal of Geriatric Oncology is the official journal of the International Society of Geriatric Oncology (SIOG). Publication information:Journal of Geriatric Oncology(ISSN 1879-4068) publishes 8 issues per year by Elsevier, 230 Park Avenue Suite 800, New York, NY 10169, USA. Periodicals Postage Paid at New York, NY and at additional mailing offices (not valid for journal supplement). USA POSTMASTER: Send address changes to Elsevier, Journal Returns, 1799 Highway 50 East, Linn, MO 65051. Orders, claims, and journal inquiries: Please visit our Support Hub page https://service.elsevier.com for assistance. © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This journal and the individual contributions contained in it are protected under copyright by Elsevier Ltd., and the following terms and conditions apply to their use: Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. For information on how to seek permission visit www.elsevier.com/permissions or call: (+44) 1865 843830 (UK) / (+1) 215 239 3804 (USA). Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations (please consult www.elsevier.com/ permissions). Electronic Storage or Usage Permission of the Publisher is required to store or use electronically any material contained in this journal, including any article or part of an article (please consult www.elsevier. com/permissions). Except as outlined above, no part of this publication may bereproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher. Notice Journals published by Elsevier comply with applicable product safety requirements. For any product safety concerns or queries, please contact our authorized representative, Elsevier B.V., at productsafety@elsevier.com Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments contained herein. Health care practitioners must exercise their professional judgement and make all treatment-related decisions based solely on the specific conditions of each patient. Because of rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. The content is provided “as-is” and Elsevier makes no representations or warranties, whether express or implied, as to the accuracy, completeness, or adequacy of any content. To the fullest extent permitted by law, Elsevier assumes no responsibility for any damages, adverse events, or liability arising from use of information contained herein including for any injury and/or damage to persons or property, whether as a matter of product liability, negligence or otherwise. Inclusion of any advertising material in this publication does not constitute a guarantee or endorsement of the quality or value of such product or service or of any of the representations or claims made by the advertiser. Language (usage and editing services) Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier’s WebShop http:// webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com for more information. Author inquiries: You can track your submitted article at http://www.elsevier.com/track-submission. You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http:// support.elsevier.com. Advertising information: Advertising orders and inquiries can be sent to: USA, Canada and South America: Elsevier Inc., 230 Park Avenue Suite 800, New York, NY 10169, USA; phone: (+1) (212) 633 3974; Europe and ROW: Sarah Ellis, Elsevier Ltd., 32 Jamestown Road, London, NW1 7BY, UK; phone: (+44) (2074) 244538; fax (+44) (2074) 244433. Funding Body Agreements and Policies Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies. ○1 The paper used in this publication meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper) Printed by Sheridan at 450 Fame Avenue, Hanover, PA 17331 For a full and complete Guide for Authors, please go to: http://www.elsevier.com/locate/jgo Publishing Office: Elsevier Ltd, 125 London Wall, London, EC2Y 5AS.
RkJQdWJsaXNoZXIy MjYwNTA2Mw==